Nonin Medical, Inc., the inventor of finger pulse oximeters and a leader in noninvasive medical monitoring, today released a Pulse Oximetry Special Report for durable medical equipment (DME) providers at Booth #953 at Medtrade 2012 in Atlanta. Medtrade is the largest home medical equipment tradeshow in the United States.
EarlySense, the market leader in proactive patient care solutions, announced today that the company has received FDA Clearance for its bedside system and central display system with oximetry integration.
Sensors for Medicine and Science, Inc., a privately held medical device company focused on the development and commercialization of the first fully implantable, long-term continuous glucose monitoring (CGM) system, today announced its new company name, Senseonics.
ARAMARK Healthcare today announced its partnership with Tru-D SmartUVC™ technology, a cutting-edge portable UV disinfection system technology, which will effectively and efficiently help prevent healthcare-associated infections (HAI's) in hospitals across North America.
Masimo announced today limited market release of the Universal ReSposable™ Pulse Oximetry Sensor System, offering the Measure-Through Motion and Low Perfusion performance and accuracy of SET®, as well as the comfort of its single-patient-use adhesive sensors with the cost-effectiveness and environmental advantages of a reusable sensor.
Micromem Technologies through its wholly owned subsidiary, Micromem Applied Sensor Technologies Inc. (MAST), is pleased to provide an update on current and new initiatives. Also, please visit our website to read the CEO's Letter to the Shareholders dated October 5, 2012.
Masimo today announced the CE Mark and debut of the new fractional arterial oxygen saturation, SpfO2™, parameter through the rainbow® Universal ReSposable SuperSensor™, the first noninvasive sensor to provide simultaneous monitoring of SpHb®, SpCO®, SpMet®, SpfO2, SpOC™, Perfusion Index, PVI®, and
Respiratory Motion, Inc. today announced 510(k) clearance from the US Food and Drug Administration (FDA) for its ExSpiron respiratory monitoring system, the first to provide continuous, noninvasive Minute Ventilation data in non-ventilated patients. A presentation on the technology will be given at the American Society of Anesthesiologists (ASA) annual conference on October 16.
Masimo today announced the FDA 510(k) clearance and market release of Masimo's new uSpO2™ universal pulse oximetry cable for use with GE Healthcare's ApexPro® Telemetry Systems. GE Healthcare is the first to integrate Masimo's low power platform with SET® Measure-Through Motion and Low Perfusion SpO2 technology into patient-worn monitors designed for use in ambulatory patient care environments.
Many diseases, including cancers, leave genetic clues in the body just as criminals leave DNA at the scene of a crime. But tools to detect the DNA-like sickness clues known as miRNAs, tend to be slow and expensive.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.